AMY MOON: Open Payments
NPI 1043305121 · ASHEBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 65 payments from 17 companies in 2025. Trend: 2023 $2,114 · 2024 $1,136 · 2025 $1,172
Food & beverage: $1,172
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $358 |
| ABBVIE INC. | 12 | $152 |
| PFIZER INC. | 5 | $110 |
| Novo Nordisk Inc | 5 | $93 |
| Amgen Inc. | 5 | $83 |
| Lilly USA, LLC | 4 | $81 |
| Eisai Inc. | 3 | $58 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
Products named: FARXIGA, AIRSUPRA, Leqembi, Ozempic, VRAYLAR, MOUNJARO, BREZTRI, UBRELVY.
Industry payments across NC — which companies pay providers there.
